NUVB Maintain Market Outperform, $10 PT after GSK FDA approval @ Citizens
NUVB Maintain Market Outperform, $10 PT after GSK FDA approval @ Citizens
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
NUVB Maintain Market Outperform, $10 PT after GSK FDA approval @ Citizens